cdn mobile

Mpox: Baguio records its first case

By: Faith Argosino - Reporter / @FArgosinoINQ January 20,2025 - 01:10 AM

Mpox: Baguio records its first case. Inquirer photo/Niño Jesus Orbeta

Inquirer photo/Niño Jesus Orbeta

MANILA, Philippines — The first case of mpox (formerly called monkeypox), a viral disease that comes with either rashes or blisters, has been logged in Baguio City. This is according to the city’s public information office.

The patient is a 28-year-old male with milder MPXV Clade II infection, Baguio City PIO citing its health services office, said in a post.

The patient had already completed isolation and was released last January 17, it further said.

READ: 

Mpox: What is it, how it spreads, care for patients

Mpox: What is it, how it spreads, care for patients

Conduct info campaign on mpox, health department, DOH-7 urged

Earlier, Health Secretary Teodoro Herbosa explained that “Mpox Clade II is transmitted by close and intimate, skin-to-skin contact and through objects touched by patients with active skin lesions.”

In September last year, assured the public that its mpox response includes prompt testing, contact tracing, and home care, pointing out that this helps them to “break chains of transmission.”

Despite the increasing cases in the country, he said the health agency will not implement any “border control or community quarantine (lockdowns).”

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: Baguio City, mpox
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.